Počet záznamov: 1  

tromboxány

  1. SYSd013931
    LBL
      
    00000cz--a2200000n--4500
    005
      
    20250606213018.3
    008
      
    920523|||anznnbabn-----------|-a|a------
    040
      
    $b slo $a DNLM $d BA006 $d BA006
    065
      
    $a D10.251.355.255.100.825
    065
      
    $a D10.251.355.310.166.971
    066
      
    $a 01 $c 03
    150
      
    $a tromboxány $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo
    450
      
    $w v $a Thromboxane $2 eng
    450
      
    $w v $a TX $2 slo
    450
      
    $w v $a tromboxán $2 slo
    450
      
    $w v $a TX $2 slo
    550
      
    $7 sllk_us_auth*d017482 $Y Receptors, Thromboxane $w p $a receptory tromboxánové
    665
      
    $a 78 $2 eng
    665
      
    $a Fatty Acids, Unsaturated (1973-1974) $2 eng
    665
      
    $a Hydroxy Acids (1975-1977) $2 eng
    665
      
    $a Pyrans (1966-1977) $2 eng
    680
    9-
    $i Physiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet aggregation, contraction of arteries, and other biological effects. Thromboxanes are important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase. $2 eng
    750
    -2
    $a Thromboxanes $2 eng
    980
      
    $x M
Počet záznamov: 1  

  Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom ako používame cookies.